Bruker AXS Wins Prestigious R&D 100 Award For Innovative VANTEC(TM)-2000 X-ray Detector Used in Materials Science ResearchBruker
July 18 2005 - 6:00AM
Business Wire
Bruker AXS Inc., a leading global provider of advanced X-ray
solutions for life and advanced materials sciences, announced today
that R&D Magazine has selected its VANTEC-2000 detector for a
2005 R&D 100 Award, which recognizes the most technologically
significant products introduced into the marketplace during the
past year. "Since its introduction, the VANTEC-2000 has
dramatically boosted the performance of X-ray diffraction (XRD)
detectors for materials research. It combines low noise, high
sensitivity, excellent spatial resolution and dynamic range with
real-time data acquisition. This even allows for snapshot and movie
mode acquisition in a virtually maintenance-free detector, that is
unrivalled in the XRD marketplace," stated Uwe Preckwinkel, the
Bruker AXS U.S. XRD Product Manager. Unlike older XRD detector
technologies, the VANTEC-2000 measures the two-dimensional X-ray
diffraction pattern from a sample. The result allows for the
calculation of a wide variety of physical parameters in a broad
range of sample types. Because of its unique capability to detect
individual photons at up to 2 million counts per second, the
detector is ideal for the analysis of weakly and/or strongly
scattering samples - including smallest sample traces, single
crystals, epitaxial thin films, coatings, rocks, polymers, metals,
steel, wood, plastics, liquids, nanomaterials and more. The award,
selected by an independent panel of judges and the editors of
R&D Magazine, "provides a mark of excellence known to industry,
government, and academia as proof that the product is one of the
most innovative ideas of the year," explained the magazine's
Editor-in-Chief, Tim Studt. About Bruker Biosciences (NASDAQ: BRKR)
Bruker BioSciences Corporation, headquartered in Billerica,
Massachusetts, is the publicly traded parent company of Bruker AXS
Inc. and Bruker Daltonics Inc. Bruker AXS is a leading worldwide
developer and provider of advanced X-ray systems which provide
solutions for molecular and elemental analysis by X-ray
crystallography, X-ray diffraction and X-ray fluorescence. Its
systems, which have particular application in the life science,
materials science and nanotechnology research fields, provide
customers with high-throughput capabilities to determine small
molecule and protein structures, or to characterize and determine
the composition and properties of advanced and nano-materials. For
more information, please visit www.bruker-axs.com. Cautionary
Statement Any statements contained in this press release with
respect to Bruker AXS or Bruker BioSciences or their businesses
that do not describe historical facts may constitute
forward-looking statements as that term is defined in the Private
Securities Litigation Reform Act of 1995. Any forward-looking
statements contained herein are based on current expectations, but
are subject to a number of risks and uncertainties. The factors
that could cause actual future results to differ materially from
current expectations include, but are not limited to, risks and
uncertainties relating to the Company's reorganization strategies,
integration risks, failure of conditions, technological approaches,
product development, market acceptance, cost and pricing of the
Company's products, changes in governmental regulations, capital
spending and government funding policies, FDA and other regulatory
approvals to the extent applicable, competition, the intellectual
property of others, patent protection and litigation. These and
other factors are identified and described in more detail in our
filings with the SEC, including, without limitation, our respective
annual reports on Form 10-K for the year ended December 31, 2004,
our most recent quarterly reports on Form 10-Q, our current reports
on Form 8-K and the joint proxy statement/prospectus filed in
connection with the merger. We disclaim any intent or obligation to
update these forward-looking statements.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Oct 2023 to Oct 2024